Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines? Academic Article uri icon

Overview

publication date

  • May 21, 2012

Research

keywords

  • Anthracyclines
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms

Identity

PubMed Central ID

  • PMC6076002

Scopus Document Identifier

  • 84864018416

Digital Object Identifier (DOI)

  • 10.1200/JCO.2012.42.0695

PubMed ID

  • 22614986

Additional Document Info

volume

  • 30

issue

  • 18